David L. Varie

747 total citations
19 papers, 490 citations indexed

About

David L. Varie is a scholar working on Organic Chemistry, Pharmacology and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, David L. Varie has authored 19 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 5 papers in Pharmacology and 5 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in David L. Varie's work include Chemical synthesis and alkaloids (6 papers), Synthetic Organic Chemistry Methods (5 papers) and Plant and fungal interactions (5 papers). David L. Varie is often cited by papers focused on Chemical synthesis and alkaloids (6 papers), Synthetic Organic Chemistry Methods (5 papers) and Plant and fungal interactions (5 papers). David L. Varie collaborates with scholars based in United States. David L. Varie's co-authors include Keith M. DeVries, Bernard A. Olsen, David A. Perry, Thomas H. Eberlein, Edwin Vedējs, Michael J. Martinelli, Roger B. Ruggeri, Daniel A. Netzel, Donald E. Linn and Thomas Kress and has published in prestigious journals such as The Journal of Organic Chemistry, Fuel and Organic Letters.

In The Last Decade

David L. Varie

19 papers receiving 454 citations

Peers

Countries citing papers authored by David L. Varie

Since Specialization

Citations

This map shows the geographic impact of David L. Varie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Varie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Varie more than expected).

Fields of papers citing papers by David L. Varie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Varie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Varie. The network helps show where David L. Varie may publish in the future.

Co-authorship network of co-authors of David L. Varie

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Varie. A scholar is included among the top collaborators of David L. Varie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Varie. David L. Varie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Improved Synthesis of C4α- and C4β-Methyl Analogues of 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylate 2012 ·Organic Letters ·Steven S. Henry, (unknown), (unknown), J. Craig Ruble, David L. Varie, James A. Monn	8
2	Development of an Enantioselective Hydrogenation Based Synthesis of a Glucokinase Activator 2012 ·Organic Process Research & Development ·Nicholas A. Magnus, Timothy M. Braden, Jonas Y. Buser, Amy C. DeBaillie, (unknown), (unknown), (unknown), David L. Varie, Thomas Wilson	19
3	Risk Assessment of Genotoxic Impurities in Marketed Compounds Administered over a Short-Term Duration: Applications to Oncology Products and Implications for Impurity Control Limits 2010 ·Organic Process Research & Development ·(unknown), Joel P. Bercu, Keith M. DeVries, (unknown), (unknown), David L. Varie	17
4	Approaches to Assessment, Testing Decisions, and Analytical Determination of Genotoxic Impurities in Drug Substances 2008 ·Organic Process Research & Development ·(unknown), Bernard A. Olsen, (unknown), Keith M. DeVries, David L. Varie	76
5	Design, Development, and Scale-Up of a Selective meso-Epoxide Desymmetrization Process 2007 ·Organic Process Research & Development ·David L. Varie, Christopher M. Beck, (unknown), (unknown), (unknown), (unknown), David Hay, (unknown), (unknown), (unknown), Richard D. Miller, Eric D. Moher, (unknown), (unknown), David D. Anderson, (unknown), (unknown), (unknown), (unknown)	16
6	Cryptophycins-309, 249 and other cryptophycin analogs: Preclinical efficacy studies with mouse and human tumors 2005 ·Investigational New Drugs ·Jian Liang, Richard E. Moore, Eric D. Moher, J. E. MUNROE, Rima Al‐awar, David Hay, David L. Varie, Tony Y. Zhang, James Aikins, Michael J. Martinelli, Chuan Shih, James E. Ray, (unknown), (unknown), Lisa Polin, Kathryn White, Juiwanna Kushner, (unknown), Susan Pugh, Thomas H. Corbett	49
7	The synthesis of (S)‐di‐n‐propyl‐(8‐isoxazol‐5‐yl‐1,2,3,4‐tetrahydronaphthalen‐2‐yl)amine hydrochloride and its C‐14‐labeled isotopomer 2004 ·Journal of Labelled Compounds and Radiopharmaceuticals ·William J. Wheeler, (unknown), Steven Swanson, Todd A. Gillespie, David L. Varie	4
8	The synthesis of carbon-14 labeled (R)-4-(dipropylamino)-1,3,4,5-tetrahydrobenz[cd]indole-6-carboxamide hippurate. A partial ergoline with 5-HT1A agonist activity and an125I-labeled analog 2004 ·Journal of Labelled Compounds and Radiopharmaceuticals ·William J. Wheeler, Steven P. Swanson, David L. Varie, (unknown)	2
9	ChemInform Abstract: Synthesis and Structure—Activity Relationship Studies of Cryptophycins: A Novel Class of Potent Antimitotic Antitumor Depsipeptides 2002 ·ChemInform ·Chuan Shih, Rima Al‐awar, (unknown), Michael J. Martinelli, Eric D. Moher, Bryan H. Norman, Vinod F. Patel, Richard M. Schultz, John E. Toth, David L. Varie, (unknown)	2
10	Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region) 1999 ·Bioorganic & Medicinal Chemistry Letters ·David L. Varie, Chuan Shih, David Hay, Sherri L. Andis, (unknown), Lynn S. Gossett, (unknown), Michael J. Martinelli, Eric D. Moher, Richard M. Schultz, John E. Toth	31
11	Bioreduction of (R)-carvone and regioselective Baeyer-Villiger oxidations: Application to the asymmetric synthesis of cryptophycin fragment A 1998 ·Tetrahedron Letters ·David L. Varie, John J. Brennan, (unknown), (unknown), David Hay, (unknown), Milton J. Zmijewski	19
12	Application of Palladium(0)-Catalyzed Processes to the Synthesis of Oxazole-Containing Partial Ergot Alkaloids 1997 ·The Journal of Organic Chemistry ·Benjamin A. Anderson, (unknown), Richard N. Booher, Michael E. Flaugh, Nancy K. Harn, Thomas Kress, David L. Varie, James P. Wepsiec	39
13	Synthetic Studies toward the Partial Ergot Alkaloid LY228729, a Potent 5HT_1A Receptor Agonist 1997 ·The Journal of Organic Chemistry ·(unknown), (unknown), (unknown), Joseph H. Kennedy, Vien V. Khau, Thomas Kress, M. Robert Leanna, (unknown), Michael J. Martinelli, (unknown), David L. Varie, James P. Wepsiec	17
14	The synthesis of (+)- and (−)-1-benzoyl-1,2,2a,3,4,5-hexahydrobenz[cd]indol-4-amine, and preparation of LY228729. 1990 ·Tetrahedron Letters ·Michael J. Martinelli, M. Robert Leanna, David L. Varie, (unknown), Thomas Kress, James P. Wepsiec, Vien V. Khau	10
15	Preparation of 1-benzoyl-4-(amino)-1,2,2a,3,4,5-hexahydrobenz[CD]indoles from L-tryptophan 1990 ·Tetrahedron Letters ·David L. Varie	12
16	Diastereoselectivity in ergoline synthesis: A face selective epoxidation 1989 ·Tetrahedron Letters ·M. Robert Leanna, Michael J. Martinelli, David L. Varie, Thomas Kress	7
17	Synthesis of 3,6-dichloro-4-(2-chloro-1,1-dimethylethyl)pyridazine 1988 ·The Journal of Organic Chemistry ·(unknown), (unknown), (unknown), David L. Varie	5
18	Thioaldehyde Diels-Alder reactions 1986 ·The Journal of Organic Chemistry ·Edwin Vedējs, Thomas H. Eberlein, (unknown), (unknown), David A. Perry, Roger B. Ruggeri, (unknown), (unknown), David L. Varie	93
19	1H- and 13C-n.m.r. studies on naphtha and light distillate saturate hydrocarbon fractions obtained from in-situ shale oil 1981 ·Fuel ·Daniel A. Netzel, (unknown), (unknown), (unknown), (unknown), David L. Varie, Donald E. Linn	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact